These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18757092)

  • 21. Heart failure management. Interview with Karl Swedberg.
    Swedberg K
    Timely Top Med Cardiovasc Dis; 2007 Jan; 11():E1. PubMed ID: 17369884
    [No Abstract]   [Full Text] [Related]  

  • 22. [Beta-blocker in secondary prevention of cardiovascular disease].
    Sauer G
    Z Kardiol; 2003 Jan; 92(1):24-30. PubMed ID: 12545298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [NMR shows how beta blockers change the failing ventricle. Decreased size and better output performance].
    MMW Fortschr Med; 2003 Jun; 145(25):56. PubMed ID: 12891860
    [No Abstract]   [Full Text] [Related]  

  • 24. Ivabradine and outcomes in chronic heart failure.
    Gupta A; Sharma YP
    Lancet; 2010 Dec; 376(9758):2069; author reply 2069-70. PubMed ID: 21168044
    [No Abstract]   [Full Text] [Related]  

  • 25. [Beta inhibitors in the treatment of chronic cardiac insufficiency, are they useful in stable but severely ill patients?].
    Martínez Martínez JA
    Medicina (B Aires); 2000; 60(5 Pt 1):665. PubMed ID: 11188912
    [No Abstract]   [Full Text] [Related]  

  • 26. [Ivabradine in patients with stable ischemic heart disease and left ventricular systolic dysfunction: the results of the BEAUTIFUL study].
    Filipovský J
    Vnitr Lek; 2009 May; 55(5):513-6. PubMed ID: 19514618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
    Swedberg K; Komajda M; Böhm M; Borer J; Robertson M; Tavazzi L; Ford I;
    J Am Coll Cardiol; 2012 May; 59(22):1938-45. PubMed ID: 22617188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Heart rate reduction as a therapeutic strategy: novel options].
    Hoppe UC
    Internist (Berl); 2006 Dec; 47(12):1289-93. PubMed ID: 17077980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of a pure reduction in heart rate for the treatment of left ventricular dysfunction: clinical benefits of ivabradine in the BEAUTIFUL trial.
    Danchin N
    Therapie; 2009; 64(2):111-4. PubMed ID: 19664404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug therapy and microvolt T-wave alternans testing.
    Jauhar S; Chinitz L; Jorde U
    Lancet; 2003 Oct; 362(9393):1417-8; author reply 1418. PubMed ID: 14585650
    [No Abstract]   [Full Text] [Related]  

  • 31. Heart rate as a treatable cardiovascular risk factor.
    Tardif JC
    Br Med Bull; 2009; 90():71-84. PubMed ID: 19474056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. It is all about heart rate. Or is it?
    Sarraf M; Francis GS
    J Am Coll Cardiol; 2012 May; 59(22):1946-7. PubMed ID: 22617189
    [No Abstract]   [Full Text] [Related]  

  • 33. [Management of hypertensive patients with cardiovascular damage].
    Tomiyama H; Takata Y; Yamashina A
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():612-6. PubMed ID: 15171444
    [No Abstract]   [Full Text] [Related]  

  • 34. [Variability of heart rate in postmyocardial infarction patients: clinical implications, problems and prospects].
    Popov VV; Kopitsa NP; Oparin AL
    Klin Med (Mosk); 1998; 76(2):15-9. PubMed ID: 9553353
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of ivabradine in a case of inappropriate sinus tachycardia and ventricular dysfunction.
    Sette A; Martino A; Lioy E; Calò L
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):815-7. PubMed ID: 20233274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [When the left ventricle can no longer relax properly. Beta blocker improves diastolic function].
    MMW Fortschr Med; 2003 Jan; 145(5):53. PubMed ID: 12619218
    [No Abstract]   [Full Text] [Related]  

  • 37. [Ivabradine in coronary heart disease: experimental and clinical pharmacology].
    Pathak A; Berdeaux A; Mulder P; Thuillez C
    Therapie; 2010; 65(5):483-9. PubMed ID: 21144484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated heart rate proven to increase coronary events.
    Fox K; Steg PG
    Cardiovasc J Afr; 2008; 19(5):276-8. PubMed ID: 18997992
    [No Abstract]   [Full Text] [Related]  

  • 39. Increased time varying heart rate and cardiovascular risk in hypertension: benefit of selective I((f)) channel inhibitor?
    Kjeldsen SE; Hedner T; Narkiewicz K; Oparil S
    Blood Press; 2012 Feb; 21(1):1-2. PubMed ID: 22263600
    [No Abstract]   [Full Text] [Related]  

  • 40. [Ivabradine -- a novel approach for heart rate lowering].
    Er F; Hoppe UC
    Dtsch Med Wochenschr; 2005 Jun; 130(24):1501-2. PubMed ID: 15942839
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.